Anauxetic dysplasia

Anauxetic dysplasia

Overview

Anauxetic dysplasia is an extremely rare, severe form of skeletal dysplasia. Meaning "not growing" in Greek, it is characterized by profound prenatal-onset dwarfism (resulting in an adult height of less than 85 cm), joint hypermobility, distinctive facial features, and mild intellectual disability.

Symptoms

Anauxetic dysplasia is an extremely rare, genetic form of dwarfism. The condition is primarily characterized by severe prenatal-onset short stature, disproportionately short limbs, joint hypermobility, distinct facial features, and mild intellectual disability.

The key symptoms and physical characteristics associated with the condition include:

Extreme short stature: Affected individuals typically have an adult height of less than one meter.

Disproportionate limbs: Arms and legs are unusually short relative to the torso, present even before birth.

Spinal issues: Abnormal curvature of the upper and lower spine (kyphoscoliosis and hyperlordosis), which can restrict the lungs and cause breathing difficulties.

Joint and bone anomalies: Unusually loose joints (hypermobility), limited elbow extension, a barrel-shaped chest, and potential hip dislocation.

Neurological Risks

Cervical spine instability: Dislocation of the bones at the top of the spine (atlantoaxial subluxation) can pinch the spinal cord.

Spinal cord compression: This can cause neurological symptoms like pain, numbness, tingling, weakness, poor coordination, or paralysis. In severe cases, it can impair the muscles needed for breathing.

Facial and Dental Features

Facial structure: A flat or sunken appearance of the midface, closely spaced eyes, and a protruding chin.

Mouth and teeth: An unusually large tongue and fewer teeth than normal (hypodontia).

Additional Symptoms

Neurological development: Mild intellectual disability is common.

Extremities: Short fingers and toes.

Causes

The specific genetic causes are broken down into distinct types based on the affected genes:

1. RMRP Gene Mutations (Anauxetic Dysplasia 1)

What it does: The RMRP Gene does not produce a protein. Instead, it creates a noncoding RNA molecule that binds with proteins to form an enzyme complex called RNase MRP.

The mutation: Alterations or mutations in this gene impair the RNase MRP complex's ability to process ribosomal RNA. This disruption severely interferes with normal cell function and skeletal development.

Inheritance: It is an autosomal recessive disorder, meaning an affected individual must inherit two copies of the mutated gene (one from each parent).

2. POP1 Gene Mutations (Anauxetic Dysplasia 2)

What it does: The POP1 gene (located on chromosome 8q22) provides instructions for creating a protein component that forms part of the RNase MRP and RNase P enzyme complexes.

The mutation: Mutations in the POP1 gene similarly disrupt the function of these enzymes, leading to profound prenatal-onset short stature, distinct facial features, and mild intellectual disability.

Inheritance: This form is also inherited in an autosomal recessive pattern.3. NEPRO Gene Mutations (Anauxetic Dysplasia 3)

What it does: The NEPRO gene (found on chromosome 3q13) also plays a critical role in the processing and maturation of ribosomal RNA, which is fundamental for cell growth and division.

The mutation: Pathogenic variants here affect ribosome assembly, contributing to the clinical presentation of Anauxetic dysplasia.

Because these conditions are inherited recessively, parents of an affected individual are typically carriers who have one mutated copy of the gene but do not show symptoms themselves. For more information on the specific manifestations and clinical outlook, you can refer to the National Institutes of Health or review the Cartilage-hair hypoplasia-anauxetic dysplasia spectrum provided by MedlinePlus.

Diagnosis

1. Clinical Evaluation

A diagnosis typically begins with a physical examination assessing:

Severe Short Stature: Prenatal onset leading to an adult height typically under 85 cm.

Joints: Unusually loose or hypermobile joints, alongside a risk for cervical spine instability.

Facial and Dental: Distinctive features such as a small midface (midface hypoplasia), prominent jaw (prognathism), and missing teeth (hypodontia).Neurological: Spinal cord compression from neck-bone instability (atlantoaxial subluxation), causing pain or weakness.

2. Radiographic (Imaging) Findings

A skeletal survey (X-rays) is used to identify hallmark bone abnormalities, which generally include:

Vertebrae: Delayed maturation of the spinal bones.

Pelvis: Small iliac bodies and shallow hip sockets.

Hands/Feet: Very short and broad finger bones (phalanges) and short metacarpals with distinct bullet-shaped middle phalanges.

3. Molecular Genetic Testing

Diagnosis is confirmed through molecular genetic testing. Anauxetic dysplasia falls under the cartilage-hair hypoplasia (CHH) spectrum and is primarily caused by pathogenic variants in the RMRP gene (though other genetic heterogeneities like ANXD1 and POP1 also exist). Identifying these biallelic mutations definitively confirms the diagnosis and assists with family planning and genetic counseling.

Treatment

Orthopedic Management

Spine monitoring: Close observation and, if necessary, surgical correction (e.g., spinal fusion) are critical for progressive kyphoscoliosis (curved spine) and hyperlordosis to prevent lung compression.

Limb deformities: Corrective osteotomies or guided-growth techniques can be used to treat severe leg bowing or lower extremity misalignments.

Anesthesia care: Due to the risk of cervical spinal instability, specialized care and vigilant neck positioning are required during any general anesthesia.

Respiratory & Dental Care

Lung function: Severe chest wall and spinal deformities can constrict the lungs, causing restrictive breathing issues. Regular pulmonary function checkups and respiratory support are essential.

Oral health: Routine dental monitoring is required to manage crowding, malocclusions, and other dental abnormalities common in this condition.

Immunologic & Hematologic Support (If Applicable)

While anauxetic dysplasia is primarily skeletal, patients on the CHH-AD spectrum may experience compromised immune systems, severe anemia, or intestinal issues. If these overlap, management may include:

Infection control: Prompt IV acyclovir for varicella (chickenpox), prophylactic antibiotics, and/or immunoglobulin replacement (IVIG).

Stem cell transplant: For severe combined immunodeficiency (SCID) or bone marrow issues, hematopoietic stem cell transplantation (HSCT) has been successfully utilized.

Type of Doctor Department : A Pediatric Orthopedist or Skeletal Dysplasia Specialist